Thomas D. Salus's Insider Trades & SAST Disclosures

Thomas D. Salus's most recent trade in Lifecore Biomedical Inc was a trade of 37,000 Performance-Based Restricted Stock Units done . Disclosure was reported to the exchange on July 8, 2025.

Share

Note

This is a custom search result for pattern Thomas D. Salus.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Lifecore Biomedical Inc	Thomas D. Salus	Chief Legal & Administration	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Jul 2025	37,000	333,000	-		-	Performance-Based Restricted Stock Units
Lifecore Biomedical Inc	Thomas D. Salus	Chief Legal & Administration	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Jul 2025	37,000	252,000 (0%)	0%		-	Common Stock
Lifecore Biomedical Inc	Thomas D. Salus	Chief Legal & Administration	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.19 per share.	08 Jul 2025	11,022	240,978 (0%)	0%	8.2	90,270	Common Stock
Lifecore Biomedical Inc	Thomas D. Salus	Chief Legal & Administration	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Apr 2025	370,000	0	-		-	Performance-Based Restricted Stock Units
Lifecore Biomedical Inc	Thomas D. Salus	Chief Legal & Administration	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Apr 2025	210,000	210,000	-		-	Incentive Stock Option (Right to Buy)
Lifecore Biomedical Inc	Thomas D. Salus	Chief Legal & Administration	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Apr 2025	170,000	215,000 (0%)	0%		-	Common Stock
Lifecore Biomedical Inc	Thomas D. Salus	Chief Legal & Administration	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Apr 2025	45,000	45,000 (0%)	0%		-	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades